Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Avalo Therapeutics, Inc.

NASDAQ: AVTX · Life Sciences · 4 alerts · CIK 1534120

Share price
$7.13Close, Nov 17
Market cap
$412M
Shares outstanding
57.82MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Avalo Therapeutics, Inc. filings on SEC EDGAR ↗

8:07 AM ET 8-K
Capital Raise

Avalo Therapeutics Capital Raise

Avalo Therapeutics entered into an at-the-market (ATM) sales agreement with Jefferies LLC to establish a program for the potential issuance and sale of up to $200 million of common stock. Simultaneously, the company terminated its existing sales agreement with TD Securities (USA) LLC (formerly TD Cowen) that had been in place since June 2025.

Counterparty
Jefferies LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.